Clinical guidance for unfractionated heparin dosing and monitoring in critically ill patients
MN Samimi, A Hale, J Schults, A Fischer… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Unfractionated heparin is a widely used anticoagulant in critically ill patients. It
has a well-established safety profile and remains an attractive option for clinicians due to its …
has a well-established safety profile and remains an attractive option for clinicians due to its …
Evaluation of the use of a heparin dose‐response test in dogs to determine the optimal heparin dose during intravascular procedures and assessment of the in vitro …
A Hellemans, N Devriendt, L Duchateau… - Veterinary Medicine …, 2024 - Wiley Online Library
Background No guidelines for administering and monitoring anticoagulants
intraprocedurally are currently available in dogs, despite the prevalence of procedures …
intraprocedurally are currently available in dogs, despite the prevalence of procedures …
Comparison of thrombodynamic tests with determination of anti-Xa activity in evaluation of the efficacy of anticoagulant therapy in patients suffering deep vein …
VV Salukhov, EV Kryukov… - Bulletin of the …, 2024 - journals.eco-vector.com
Deep vein thrombosis of the lower extremities remains an important medical and social
problem in practical medicine. Currently, a weight-dependent low-molecular-weight heparin …
problem in practical medicine. Currently, a weight-dependent low-molecular-weight heparin …
Thrombin generation assay in COVID-19 patients shows a hypocoagulable pattern
GL Tiscia, D Colaizzo, A De Laurenzo… - … and Vascular Biology, 2024 - btvb.org
Patients with COVID-19 often exhibit coagulopathy, which can significantly impact
prognosis. Therefore, investigating coagulation in this context is clinically relevant. The …
prognosis. Therefore, investigating coagulation in this context is clinically relevant. The …